Newsmeme!
Discover News you didn't know existed
Preclinical
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Deadly Leukemia Stem Cells Found And Eliminated By New Targeted Therapy
Published July 4, 2009, 3:09 am, Medical News Today
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.
Research and Markets: Clinical Trials Handbook: Best Practices for Conducting Effective and Safe Clinical Trials
Published July 3, 2009, 9:45 am, Business Wire via Yahoo! Finance
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Clinical Trials Handbook" to their offering.
Research and Markets: Drug Safety Evaluation, 2nd Edition - Updated and Expanded Safety Guide to All Aspects of the ...
Published July 3, 2009, 8:12 am, Business Wire via Yahoo! Finance
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Drug Safety Evaluation, 2nd Edition" to their offering.
Therapy Eliminates Deadly Leukemia Stem Cells
Published July 3, 2009, 7:00 am, redOrbit
A recent study describes a novel therapeutic approach which significantly advances the fight against the deadly human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.AML is a cancer of the white blood cells that has an extremely poor prognosis and does not respond well to conventional chemotherapy.
Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
Published July 3, 2009, 6:59 am, redOrbit
SHANGHAI, July 3 /PRNewswire-Asia/ -- Sundia MediTech, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr.
New Drug Could Work Against Leukemia
Published July 3, 2009, 5:48 am, HealthCentral
Researchers see promise for treatment of AML and other cancers.
Spanish Government Selects Novavax's VLP Technology For Comprehensive Flu Vaccine Solution In Spain
Published July 3, 2009, 5:07 am, Medical News Today
Novavax, Inc. (Nasdaq: NVAX) announced its initial agreement to license its proprietary, recombinant virus-like-particle (VLP) vaccine technology to ROVI Pharmaceuticals (Madrid: ROVI) of Spain.
My Pharmiweb.com
Published July 3, 2009, 4:49 am, PharmiWeb
Oslo, Norway, 3 July 2009 - Clavis Pharma ASA (OSE: CLAVIS) announces today that it has received clearance by the United States Food and Drug Administration (FDA) to include patients in the USA in its phase II clinical programme for Intravenous CP-4126.
Intravenous COTI-2 In Combination With Doxil® (Doxorubicin HCl) Is More Effective Than Treatment With Doxil Alone In ...
Published July 3, 2009, 4:46 am, BioresearchOnline
Critical Outcome Technologies Inc. (TSX VENTURE:COT), announced positive results today from combination agent animal experiments carried out at a prominent American cancer research facility.
Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
Published July 3, 2009, 4:00 am, PR Newswire via Yahoo! Finance
Sundia MediTech, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr. Chen Chen has been appointed Senior Vice President of Chemistry Services.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |